BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 38252041)

  • 21. Monkeypox (Mpox) requires continued surveillance, vaccines, therapeutics and mitigating strategies.
    Roper RL; Garzino-Demo A; Del Rio C; Bréchot C; Gallo R; Hall W; Esparza J; Reitz M; Schinazi RF; Parrington M; Tartaglia J; Koopmans M; Osorio J; Nitsche A; Huan TB; LeDuc J; Gessain A; Weaver S; Mahalingam S; Abimiku A; Vahlne A; Segales J; Wang L; Isaacs SN; Osterhaus A; Scheuermann RH; McFadden G
    Vaccine; 2023 May; 41(20):3171-3177. PubMed ID: 37088603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A systematic review to identify novel clinical characteristics of monkeypox virus infection and therapeutic and preventive strategies to combat the virus.
    Chenchula S; Ghanta MK; Amerneni KC; Rajakarunakaran P; Chandra MB; Chavan M; Gupta R
    Arch Virol; 2023 Jun; 168(7):195. PubMed ID: 37386209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 40-Year-Old Man with Anemia, Proctitis, Rectal Bleeding, and a Perianal Rash Due to Mpox (Monkeypox) Infection.
    Moore C; Marcucci V; Torres P; Liu E; Parker GS
    Am J Case Rep; 2023 Sep; 24():e940177. PubMed ID: 37660250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022.
    Contag CA; Mische L; Fong I; Karan A; Vaidya A; McCormick DW; Bower W; Hacker JK; Johnson K; SanJuan P; Crebbin L; Temmins C; Sahni H; Bogler Y; Cooper JD; Narasimhan S
    Emerg Infect Dis; 2023 Dec; 29(12):2520-2523. PubMed ID: 37856215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report: atypical presentation of mpox with massive hematochezia and prolonged viral shedding despite tecovirimat treatment.
    Shin SU; Jung Y; Kim SE; Kim DM
    BMC Infect Dis; 2024 Feb; 24(1):183. PubMed ID: 38342913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical considerations on monkeypox antiviral medications: An overview.
    Pourkarim F; Entezari-Maleki T
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01164. PubMed ID: 38149674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on monkeypox virus infection: Focusing current treatment and prevention approaches.
    Dhapola R; Kumari S; Sharma P; KumarKushawaha P; HariKrishnaReddy D
    Fundam Clin Pharmacol; 2024 Jun; 38(3):465-478. PubMed ID: 38226405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mpox and Monkeypox Virus: Special Considerations for Athletes in Contact Sports.
    Smoliga JM
    Sports Med; 2023 Jul; 53(7):1301-1313. PubMed ID: 36848020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early administration of tecovirimat shortens the time to mpox clearance in a model of human infection.
    Nguyen BT; Marc A; Suñer C; Marks M; Ubals M; Hernández-Rodríguez Á; Melendez MÁ; ; Hruby DE; Russo AT; Mentré F; Mitjà O; Grosenbach DW; Guedj J
    PLoS Biol; 2023 Dec; 21(12):e3002249. PubMed ID: 38127878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and viral load variations of Mpox: a retrospective study in Chongqing, China.
    Yang S; Xia C; Zhang Y; Shen Y; Xia C; Lu Y; Su S; Deng C; Harypursat V; Wang J; Yuan J; Chen Y
    BMC Infect Dis; 2024 Jun; 24(1):641. PubMed ID: 38926635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The CDC Domestic Mpox Response - United States, 2022-2023.
    McQuiston JH; Braden CR; Bowen MD; McCollum AM; McDonald R; Carnes N; Carter RJ; Christie A; Doty JB; Ellington S; Fehrenbach SN; Gundlapalli AV; Hutson CL; Kachur RE; Maitland A; Pearson CM; Prejean J; Quilter LAS; Rao AK; Yu Y; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):547-552. PubMed ID: 37200231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tecovirimat for the treatment of severe Mpox in Germany.
    Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
    Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monkeypox virus-associated meningoencephalitis diagnosed by detection of intrathecal antibody production.
    Karin H; Ylva B; Sandra S; Aleksandra P; Per B; Klara S
    BMC Infect Dis; 2024 Jan; 24(1):94. PubMed ID: 38229022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications.
    Pinnetti C; Cimini E; Mazzotta V; Matusali G; Vergori A; Mondi A; Rueca M; Batzella S; Tartaglia E; Bettini A; Notari S; Rubino M; Tempestilli M; Pareo C; Falasca L; Del Nonno F; Scarabello A; Camici M; Gagliardini R; Girardi E; Vaia F; Maggi F; Agrati C; Antinori A
    Lancet Infect Dis; 2024 Feb; 24(2):e127-e135. PubMed ID: 37778364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mpox Person-to-Person Transmission-Where Have We Got So Far? A Systematic Review.
    Pinto P; Costa MA; Gonçalves MFM; Rodrigues AG; Lisboa C
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 2022 monkeypox outbreak 1 year on: The 5 Ws.
    Khan G; Perveen N
    Rev Med Virol; 2024 Jan; 34(1):e2489. PubMed ID: 37930054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic Manifestations of Monkeypox Virus Infection: A Cases Series.
    Curi ALL; Rojas-Carabali W; Talero-Gutiérrez C; Cifuentes-González C; Biancardi Barreto AL; Carvalho EM; de-la-Torre A
    Ocul Immunol Inflamm; 2024 Apr; 32(3):262-265. PubMed ID: 36854135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-Healing Corneal Ulcer and Uveitis Following Monkeypox Disease: Diagnostic and Therapeutic Challenges.
    Androudi S; Kaufman AR; Kouvalakis A; Mitsios A; Sapounas S; Al-Khatib D; Schibler M; Pineda R; Baglivo E
    Ocul Immunol Inflamm; 2024 Apr; 32(3):253-258. PubMed ID: 37140328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
    Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
    Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Position Statement on Mpox as a Sexually Transmitted Disease.
    Allan-Blitz LT; Gandhi M; Adamson P; Park I; Bolan G; Klausner JD
    Clin Infect Dis; 2023 Apr; 76(8):1508-1512. PubMed ID: 36546646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.